1. Home
  2. CVAC vs EOSE Comparison

CVAC vs EOSE Comparison

Compare CVAC & EOSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVAC
  • EOSE
  • Stock Information
  • Founded
  • CVAC 2000
  • EOSE 2008
  • Country
  • CVAC Germany
  • EOSE United States
  • Employees
  • CVAC N/A
  • EOSE N/A
  • Industry
  • CVAC Biotechnology: Pharmaceutical Preparations
  • EOSE Industrial Machinery/Components
  • Sector
  • CVAC Health Care
  • EOSE Miscellaneous
  • Exchange
  • CVAC Nasdaq
  • EOSE Nasdaq
  • Market Cap
  • CVAC 637.1M
  • EOSE 542.2M
  • IPO Year
  • CVAC 2020
  • EOSE N/A
  • Fundamental
  • Price
  • CVAC $2.54
  • EOSE $2.19
  • Analyst Decision
  • CVAC Hold
  • EOSE Strong Buy
  • Analyst Count
  • CVAC 3
  • EOSE 6
  • Target Price
  • CVAC $10.00
  • EOSE $5.42
  • AVG Volume (30 Days)
  • CVAC 540.3K
  • EOSE 7.5M
  • Earning Date
  • CVAC 11-12-2024
  • EOSE 11-05-2024
  • Dividend Yield
  • CVAC N/A
  • EOSE N/A
  • EPS Growth
  • CVAC N/A
  • EOSE N/A
  • EPS
  • CVAC N/A
  • EOSE N/A
  • Revenue
  • CVAC $70,565,734.00
  • EOSE $14,963,000.00
  • Revenue This Year
  • CVAC $123.97
  • EOSE $187.90
  • Revenue Next Year
  • CVAC N/A
  • EOSE $391.53
  • P/E Ratio
  • CVAC N/A
  • EOSE N/A
  • Revenue Growth
  • CVAC 75.11
  • EOSE 20.34
  • 52 Week Low
  • CVAC $2.22
  • EOSE $0.61
  • 52 Week High
  • CVAC $6.30
  • EOSE $3.66
  • Technical
  • Relative Strength Index (RSI)
  • CVAC 34.97
  • EOSE 33.48
  • Support Level
  • CVAC $2.73
  • EOSE $2.23
  • Resistance Level
  • CVAC $2.97
  • EOSE $2.52
  • Average True Range (ATR)
  • CVAC 0.18
  • EOSE 0.26
  • MACD
  • CVAC -0.01
  • EOSE -0.12
  • Stochastic Oscillator
  • CVAC 7.55
  • EOSE 2.11

About CVAC CureVac N.V.

CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.

About EOSE Eos Energy Enterprises Inc.

Eos Energy Enterprises Inc designs develop, manufactures, and markets zinc-based energy storage solutions for utility-scale, microgrid, and commercial & industrial (C&I) applications. The solutions are used in the utility sector, the renewable energy sector, and the industrial sector. It's flagship product Eos Znyth is a stationary battery energy storage system.

Share on Social Networks: